e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
Cell biology of lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Surfactant protein D is critical for local immunomodulation in the distal lung
M. Beers, D. Jain, F. Blank, Y. Tomer, C. von Garnier (Philadelphia, United States Of America; Bern, Switzerland)
Source:
Annual Congress 2011 - Cell biology of lung disease
Session:
Cell biology of lung disease
Session type:
Thematic Poster Session
Number:
3886
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Beers, D. Jain, F. Blank, Y. Tomer, C. von Garnier (Philadelphia, United States Of America; Bern, Switzerland). Surfactant protein D is critical for local immunomodulation in the distal lung. Eur Respir J 2011; 38: Suppl. 55, 3886
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Risk factors associated with the development of interstitial lung abnormalities
The impact of anti-IgE treatment on the airway microbiome in asthma.
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Related content which might interest you:
Surfactant protein D as a potential serum marker of pulmonary emphysema
Source: Annual Congress 2011 - Smoking-related disorders and smoking prevention
Year: 2011
Surfactant pretreatment preserves lung function in ischemia-reperfusion-injury of the lung
Source: Eur Respir J 2005; 26: Suppl. 49, 221s
Year: 2005
Loss of structural integrity and function of surfactant protein D (SP-D) by cystic fibrosis- related proteases
Source: Eur Respir J 2001; 18: Suppl. 33, 537s
Year: 2001
Role of
ABCA3
in paediatric interstitial lung disease associated with surfactant protein C gene mutations
Source: Annual Congress 2009 - Genetics of lung diseases
Year: 2009
Translocation of TNF-α from the gut to the lung by VILI is reduced by exogenous surfactant therapy
Source: Eur Respir J 2002; 20: Suppl. 38, 375s
Year: 2002
Serum surfactant protein D (SP-D) is a lung derived biomarker for COPD that is responsive to treatment with oral corticosteroids
Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD
Year: 2008
Surfactant protein D influences allergic immune responses
Source: Eur Respir J 2003; 22: Suppl. 45, 194s
Year: 2003
The role of vitamin D in regulating the severity and duration of murine lung injury
Source: Annual Congress 2013 –Acute lung injury: novel clinical and experimental insights
Year: 2013
HDAC inhibitors may regulate EMT and surfactant protein C in human alveolar epithelial cells
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
A novel non-BRICHOS surfactant protein C mutation causing infantile interstitial lung disease is associated with reduced mature SP-C level
Source: International Congress 2018 – Orphan diseases in children
Year: 2018
Oral presentation: Vitamin D binding protein is functionally important in airway infections
Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung
Year: 2010
Surfactant protein A (SP-A) and alveolar complement activation in patients at-risk for ARDS
Source: Eur Respir J 2002; 20: Suppl. 38, 375s
Year: 2002
Lung function is improved by surfactant pre-treatment in ischemia-reperfusion-injury of the lung
Source: Eur Respir J 2004; 24: Suppl. 48, 204s
Year: 2004
Activated protein C protection in endotoxin-induced lung injury is mediated by lung matrix metalloproteinases activity
Source: Annual Congress 2007 - Miscellaneous lower respiratory tract infections
Year: 2007
Surfactant protein gene A, B, and D marker alleles in chronic obstructive pulmonary disease of a Mexican population
Source: Eur Respir J 2001; 18: 482-490
Year: 2001
Inhaled activated protein C protects mice from ventilator-induced lung injury
Source: Annual Congress 2009 - Acute lung injury: biological mechanisms
Year: 2009
Barrier-protective effects of activated protein C in human alveolar epithelial cells
Source: Annual Congress 2013 –Experimental models in critical care
Year: 2013
Surfactant protein A modulate bleomycin-induced lung injury in toll-like receptor 2 dependent pathway
Source: Annual Congress 2010 - Determinants of acute lung injury and fibrosis
Year: 2010
Plasma surfactant protein D (SP-D) and nutritive status in patients with COPD
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
LSC - 2019 - Surfactant protein SP-D to the rescue of NETosis and NET-induced lung surfactant inactivation
Source: International Congress 2019 – Injury and repair: less is more
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept